VR Logo

Orion Biotech Opportunities Corp. Class A (ORIA) download report


Financial | Investment Services

Orion Biotech Opportunities Corp. Class A (ORIA) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities.

IPO Date: 13-Jul-2021

CEO & Director: Mr. Zuie-Chin Huang M.B.A.

CFO & Sec.: Mr. Mark Kayal

Listing: NASDAQ: ORIA

Country: United States

Headquarters: New York, NY

Website: https://orionbiotechopportunities.com

Key Facts

Market cap: $246.25 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $3.87 Mln

Cash: $0.58 Mln

Total Debt: $0.00 Mln

Insider's Holding: 7.50%

Liquidity: Low

52 Week range: $9.45 - 10.78

Shares outstanding: 20,000,000

Stock Performance

Time Period Orion Biotech Opportunities Corp. Class A (ORIA) S&P BSE Finance* S&P Small-Cap 600*
YTD0.91-11.20-18.40
1 month-0.10-6.33-8.42
3 months0.41-7.93-14.06
1 Year---8.94-17.64
3 Years--2.376.75
5 Years--6.246.18
10 Years----10.23
As on 28-Jun-2022 *As on 29-Jun-2022